Robert Kleinknecht v. HHS - Tdap, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (2022)

Filed 2022-03-01Decided 2022-03-28Vaccine Tdap
compensated$250,000

Case summary [AI summaries can sometimes make mistakes]

Robert Kleinknecht filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging that he suffered from Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) after receiving a Tdap vaccine. The petition stated that his condition had residual effects for more than six months and that the vaccine was administered in the United States.

Respondent denied that the vaccine caused petitioner’s alleged CIDP or any other injury. Despite the denial, the parties filed a joint stipulation for damages, agreeing that compensation should be awarded.

The court found the stipulation reasonable and adopted it as the decision of the Court. Robert Kleinknecht was awarded a lump sum of $250,000.00, representing compensation for all items of damages available under the Vaccine Act.

The decision was entered on March 28, 2022, following the petition filed on March 1, 2022.

Source PDFs 2 total · 1 downloaded